SCHEMBL13041551

SCHEMBL13041551

CCc1sc(-c2ccc3ccccc3c2)nc1C1C(=O)C(C)(C)OC(C)(C)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 1/20 0.39
▸ GLA P06280 5/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ DHFR P00374 1/20 0.34
▸ TYMS P04818 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ CDC25B P30305 2/20 0.32
▸ DUSP3 P51452 2/20 0.32
▸ CDC25A P30304 1/20 0.32
▸ CDC25C P30307 1/20 0.32
▸ GSTP1 P09211 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13041543 0.87 L3MBTL1 (0.44) GLAPTGDR2KDM4EALDH1A1MAPT
SCHEMBL2762937 0.83 HRH3 (0.41) PTGDR2KDM4EALDH1A1LMNAMAPT
SCHEMBL13041483 0.83 PTGDR2 (0.37) GLATDP1PTGDR2KDM4EALDH1A1
SCHEMBL13041546 0.83 DCK (0.42) PTGDR2LMNAMAPT
SCHEMBL13041549 0.80 NPC1 (0.41) KDM4EALDH1A1MAPTSMN1; SMN2
SCHEMBL13041513 0.80 RAB9A (0.36) PTPN11PTGDR2ALDH1A1MAPTL3MBTL1
SCHEMBL10238124 0.78 SLC6A3 (0.39) PTPN11GLATDP1PTGDR2ALDH1A1
SCHEMBL13041491 0.75 KDM4E (0.40) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL13041511 0.74 GLA (0.36) GLATDP1PTGDR2KDM4EALDH1A1
SCHEMBL13077790 0.73 L3MBTL1 (0.43) GLAPTGDR2KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956999-B2 Herbicides SYNGENTA LIMITED (GB) 2015-02-17 — — US disclosed
US-8956999-B2 Herbicides SYNGENTA LIMITED (GB) 2015-02-17 — — US disclosed
EP-2173727-B1 NOVEL HERBICIDES SYNGENTA LTD (GB) 2013-11-06 — — EP disclosed
US-20100279868-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-11-04 — — US disclosed
US-20100279868-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-11-04 — — US disclosed
WO-2009000533-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2008-12-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279868-A1 NOVEL HERBICIDES DDT, HPD, HSD17B1 PTPN11 1281/4885GLA 3973/4885TDP1 2119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback